Meeting Program

13:00–13:15 Opening and welcome

• Words of welcome
  Konstanze Döhner (Germany)
  Claire Harrison (United Kingdom)
  Shahram Kordasti (United Kingdom)

13:15–14:15 Session 1: Diagnosis, Classification and Risk Assessment in 2026

Chair: Catherine Cargo (United Kingdom)

• Acute myeloid leukemia
  Speaker to be announced
• Myeloproliferative neoplasms
  Speaker to be announced
• Myelodysplastic synsdromes
  Catherine Cargo (United Kingdom)

14:15–15:15 Oral Abstract Session 1

15:15–15:30 Coffee break

15:30–16:30 Session 2: Future Diagnostic Platforms and Educational Needs – Data Overload

Torsten Haferlach (Germany) & Matteo Della Porta (Italy)

• Title to be announced
  Torsten Haferlach (Germany)
• Title to be announced
  Matteo Della Porta (Italy)

16:30–17:15 Debate: Frailty – When the patient is not eligible for any treatment

Chair to be announced

• Debaters
  Speaker to be announced
  Adriano Venditti (Italy)

17:15–17:30 Coffee break

17:30–18:15 Satellite symposium 1

18:15–19:15 Welcome Reception + Poster session

08:00–08:45 Meet the Experts Breakfast

09:00–10:00 Session 3: Genomics in MPN, MDS, AML

Chair: Paolo Guglielmelli (Italy)

• Acute myeloid leukemia
  Lars Bullinger (Germany)
• Myeloproliferative neoplasms
  Paolo Guglielmelli (Italy)
• Myelodysplastic synsdromes
  Speaker to be announced

10:00–11:00 Session 4: Microenvironment, proteomics, and microbiome

Chair: Dominique Bonnet (United Kingdom)

• Niche
  Dominique Bonnet (United Kingdom)
• Microbiome
  Saeed Shoaie (United Kingdom)
• Proteims and metabolomics
  Speaker to be announced

11:00–11:15 Coffee break

11:15–12:15 Session 5: Immunome in MPN, MDS and AML – What Is It and How to Target?

Chairs: Shahram Kordasti (United Kingdom) & Arjan van de Loosdrecht (The Netherlands)

• Acute myeloid leukemia
  Speaker to be announced
• Myeloproliferative neoplasms
  Philipp Jost (Austria)
• Myelodysplastic synsdromes
  Arjan van de Loosdrecht (The Netherlands)

12:15–13:30 Lunch break

13:00–13:45 Satellite Symposium 3

13:45–14:45 Session 6: Treatment of MPN in 2026

Chairs: Claire Harrison (United Kingdom) & Jean-Jacques Kiladjian (France)

• CALR antibody treatment
  Claire Harrison (United Kingdom)
• MRD included
  Jean-Jacques Kiladjian (France)
• Transplant in MPN
  Speaker to be announced

14:45–15:00 Coffee break

15:00–16:00 Session 7: Treatment of MDS in 2026

Chair: Antonio Almeida (Portugal)

• Low-risk
  Antonio Almeida (Portugal)
• High-risk
  Maria Teresa Voso (Italy)
• Novel agents
  Speaker to be announced

16:00–16:45 Debate: Immunotherapy in MDS, a finished story?

Chair: Arjan van de Loosdrecht (The Netherlands)

• Debaters
  Shahram Kordasti (United Kingdom)
  Speaker to be announced

16:45–17:00 Coffee break

17:00–17:45 Satellite Symposium 2

09:00–10:00 Session 8: Treatment of AML in 2026

Chair: Konstanze Döhner (Germany)

• Combination therapy using novel drugs for patients fit for intensive therapy
  Speaker to be announced
• Combination therapy using novel drugs for patients unfit for intensive therapy
  Alessandro Isidori (Italy)
• Novel aspects of MRD monitoring
  Konstanze Döhner (Germany)

10:00–11:00 Oral Abstract Session 2

11:00–11:15 Coffee break

11:15–12:00 Session 9: Challenging Clinical Cases

Chairs: Alesia Khan (United Kingdom) & Sanam Loghavi (United States)

• MDS/MPN (case)
  Alesia Khan (United Kingdom)
• Hematopathologist review
  Sanam Loghavi (United States)
• Expert panel
  All speakers

12:00–12:15 Closing ceremony

• Closing remarks
  Konstanze Döhner (Germany)
  Claire Harrison (United Kingdom)
  Shahram Kordasti (United Kingdom)

12:15–13:00 Farewell lunch